Treatment outcomes following continuous miglustat therapy in
Por um escritor misterioso
Last updated 19 junho 2024
Background Niemann-Pick disease Type C (NP-C) is a rare, progressive neurodegenerative disorder characterized by progressive neurodegeneration and premature death. We report data at closure of the NPC Registry that describes the natural history, disease course and treatment experience of NP-C patients in a real-world setting. Methods The NPC Registry was a prospective observational cohort study that ran between September 2009 and October 2017. Patients with a confirmed diagnosis of NP-C were enrolled regardless of treatment status. All patients underwent clinical assessments and medical care as determined by their physicians; data were collected through a secure internet-based portal. Results At closure on October 19, 2017, 472 patients from 22 countries were enrolled in the NPC Registry. Mean (standard deviation) age at enrollment was 21.2 (15.0) years, and 51.9% of patients were male. First neurological symptom onset occurred during the early-infantile (< 2 years), late-infantile (2 to < 6 years), juvenile (6 to < 15 years), or adolescent/adult (≥ 15 years) periods in 13.5, 25.6, 31.8, and 29.1% of cases, respectively. The most frequent neurological manifestations prior to enrollment included ataxia (67.9%), vertical supranuclear gaze palsy (67.4%), dysarthria (64.7%), cognitive impairment (62.7%), dysphagia (49.1%), and dystonia (40.2%). During infancy, splenomegaly and hepatomegaly were frequent (n = 199/398 [50%] and n = 147/397 [37.0%], respectively) and persisted in most affected patients. Of the 472 enrolled patients, 241 were continuously treated with miglustat during the NPC Registry observation period, of whom 172 of these 241 patients were treated continuously for ≥12 months. A composite disability score that assesses impairment of ambulation, manipulation, language, and swallowing was highest in the early-infantile population and lowest in the adolescent/adult population. Among the continuous miglustat therapy population, 70.5% of patients had improved or had stable disease (at least 3 of the 4 domains having a decreased or unchanged score between enrollment and last follow-up). The NPC Registry did not identify any new safety signals associated with miglustat therapy. Conclusions The profiles of clinical manifestations in the final NPC Registry dataset agreed with previous clinical descriptions. Miglustat therapy was associated with a stabilization of neurological manifestations in most patients. The safety and tolerability of miglustat therapy was consistent with previous reports.
Proportions of patients who received continuous miglustat therapy
Clinical trials with Miglustat (Zavesca ® )
Small Molecules: Substrate Inhibitors, Chaperones, Stop-Codon Read
Estimating the prevalence of Niemann-Pick disease type C (NPC) in
PDF) Treatment outcomes following continuous miglustat therapy in
PDF) Treatment outcomes following continuous miglustat therapy in
COVID-19 therapeutics: Challenges and directions for the future
These highlights do not include all the information needed to use
The development and use of small molecule inhibitors of
JCM, Free Full-Text
Stable or improved neurological manifestations during miglustat
Estimating the prevalence of Niemann-Pick disease type C (NPC) in
Treatment outcomes following continuous miglustat therapy in
Effects of Miglustat on Stabilization of Neurological Disorder in
Miglustat: Package Insert
Recomendado para você
-
Niemann-Pick-C desease - CERMO-FC19 junho 2024
-
Niemann Pick Disease - Rivin19 junho 2024
-
Niemann Pick disease19 junho 2024
-
Niemann-Pick disease: Darlington man's charity walk plan raises19 junho 2024
-
Morphology of Niemann-Pick type A metabolic storage disorder19 junho 2024
-
Diagnostic and predictive methods for a Niemann-Pick disease type19 junho 2024
-
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological19 junho 2024
-
High Yielding Shorts-111 (#HYS-111):Niemann-Pick Disease Dr Devesh19 junho 2024
-
Gene therapy shows promise for treating Niemann-Pick disease type19 junho 2024
-
Baby With Niemann-Pick Disease — Marian McGlocklin Story19 junho 2024
você pode gostar
-
Raikou Raid Guide Infographic by Team gtr-Storm : r/TheSilphRoad19 junho 2024
-
Seven great space operas - The Skinny19 junho 2024
-
CHARA (Undertale/CMC+ V7/0.9.4) [Super Smash Bros. Crusade] [Mods]19 junho 2024
-
Wallpaper 4k zoro Fotos en 4k, Imagenes de luffy, Fotos de piratas19 junho 2024
-
A Google Play Store agora está aberta para PWA's, by Iago Cavalcante, devtranslate19 junho 2024
-
Daniil Medvedev Defeats Novak Djokovic in Dubai, ATP Tour19 junho 2024
-
Fantasias masculinas estilosas para o carnaval! Listamos 4 fantasias p19 junho 2024
-
The Hidden Truth and True Power of the Ope Ope No Mi - One Piece19 junho 2024
-
Console Game Stick Lite 4K - com desconto de % no Paraguai19 junho 2024
-
From Contagion to Station Eleven, Why Are Folks Craving Apocalyptic Content During a Pandemic?19 junho 2024